Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.40 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.39 |
| ▸ | PRKCG | P05129 | 1/20 | 0.39 |
| ▸ | PRKCB | P05771 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.39 |
| ▸ | PRKCH | P24723 | 1/20 | 0.39 |
| ▸ | PRKCI | P41743 | 1/20 | 0.39 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.39 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.39 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.39 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.39 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6016025 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL9521214 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL15201698 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL7720721 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL15963880 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL6015980 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL8668910 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL9521223 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL9563973 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG | |
| SCHEMBL12427214 | 1.00 | PTGS1 (0.40) | PTGS1PTGS2SLC2A1PRKD3PRKCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104945457-A | 1-(1',3',4',6'-tetra-O-acetyl-D-glucose)-4-para-substituted aromatic-[1,2,3]-triazole, preparation method and application thereof | UNIV HUBEI ENGINEERING | 2015-09-30 | — | — | CN | claimed |
| CN-104945456-A | 2-(1',2',3'-triazolyl-4'-oxymethylenepyridyl)-1,3,4,6-O-acetyl-D-glucose and its preparation method and use | UNIV HUBEI ENGINEERING | 2015-09-30 | — | — | CN | claimed |
| CN-104817605-A | 2-(1',2',3'-triazole-4'-benzyloxy)-1,3,4,6-O-acetyl-D-glucose and preparation method and application thereof | UNIV HUBEI ENGINEERING | 2015-08-05 | — | — | CN | claimed |
| CN-115997819-A | Set yoghurt fermented by binary probiotics and medlar dietary fibers, preparation method thereof and construction of flavor substance fingerprint | 宁波大学 | 2023-04-25 | — | — | CN | disclosed |
| US-20210161189-A1 | MONOESTER SUGAR DERIVATIVES AS FLAVOR MODIFIERS | FIRMENICH SA (CH) | 2021-06-03 | — | — | US | disclosed |
| CN-105175470-A | Arsenic sugar compound with anti-tumor activity and preparation method therefor and application thereof | UNIV HUBEI ENGINEERING | 2015-12-23 | — | — | CN | disclosed |
| CN-104945457-A | 1-(1',3',4',6'-tetra-O-acetyl-D-glucose)-4-para-substituted aromatic-[1,2,3]-triazole, preparation method and application thereof | UNIV HUBEI ENGINEERING | 2015-09-30 | — | — | CN | disclosed |
| CN-104945456-A | 2-(1',2',3'-triazolyl-4'-oxymethylenepyridyl)-1,3,4,6-O-acetyl-D-glucose and its preparation method and use | UNIV HUBEI ENGINEERING | 2015-09-30 | — | — | CN | disclosed |
| CN-104817605-A | 2-(1',2',3'-triazole-4'-benzyloxy)-1,3,4,6-O-acetyl-D-glucose and preparation method and application thereof | UNIV HUBEI ENGINEERING | 2015-08-05 | — | — | CN | disclosed |
| CN-101514216-B | Synthesis method of saffron glucoside | UNIV SICHUAN | 2012-05-23 | — | — | CN | disclosed |
| CN-101514216-A | Method for synthesizing crocin glucoside | UNIV SICHUAN (CN) | 2009-08-26 | — | — | CN | disclosed |
| EP-1361870-A2 | A SUBSTANCE FOR USE IN A DIETARY SUPPLEMENT OR FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERTENSION AND/OR THE METABOLIC SYNDROME | Nutri Pharma ASA (NO) | 2003-11-19 | — | — | EP | disclosed |
| WO-2002060419-A2 | A SUBSTANCE FOR USE IN A DIETARY SUPPLEMENT OR FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS, HYPERTENSION AND/OR THE METABOLIC SYNDROME | NUTRI PHARMA ASA (NO) | 2002-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210161189-A1 | MONOESTER SUGAR DERIVATIVES AS FLAVOR MODIFIERS | TAS2R40, TAS2R30, TAS2R50 | PTGS1 4117/4885PTGS2 4529/4885SLC2A1 187/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.